James Halley
XMFjimhalley
Recent Articles by James Halley

Nov 12, 2020
by James Halley
Does Good News About Biogen's Alzheimer's Drug Mean Bad News for Rivals?
Biogen's Alzheimer's disease drug, aducanumab, got positive news from the FDA last week. If the drug is approved, what does that mean for other companies with prospective Alzheimer's drug candidates?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.